# Contract Orientation and Kickoff Meeting

> **NIH NIH N01** · WEILL MEDICAL COLL OF CORNELL UNIV · 2024 · $3,500

## Abstract

This contract supports the PREVENT Cancer Preclinical Drug Development Program, which provides a structured approach to drug and vaccine development, from discovery to the clinic. This contract is a part of a multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) pool to procure services related to Preclinical
Efficacy and Intermediate Endpoint Biomarkers, which is also referred to as the Efficacy Pool.

## Key facts

- **NIH application ID:** 11020341
- **Project number:** 75N91024D00006-0-759102400001-1
- **Recipient organization:** WEILL MEDICAL COLL OF CORNELL UNIV
- **Principal Investigator:** Steven M Lipkin
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $3,500
- **Award type:** —
- **Project period:** 2024-01-25 → 2029-01-24

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11020341

## Citation

> US National Institutes of Health, RePORTER application 11020341, Contract Orientation and Kickoff Meeting (75N91024D00006-0-759102400001-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/11020341. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*